Neonates Anthropometric Indexes. Abnormal haematological finding on antenatal screening of mother 028
Conditions
Interventions
Intervention 1: Intervention group: One ferrous sulphate pill containing 50 mg iron, per day from the 20th weeks to the end of pregnany. Intervention 2: Control group: One placebo tablet per day from
Placebo
Treatment - Drugs
Intervention group: One ferrous sulphate pill containing 50 mg iron, per day from the 20th weeks to the end of pregnany.
Control group: One placebo tablet per day from the 20th weeks to the end of pregnancy
Sponsors
Tarbiat Modarres University
Eligibility
Sex/Gender
Female
Age
17 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age 17-35; Hb higher than 13.2 gr/dl in 13-18 W of pregnancy; Single gestation; BMI=19.8-26; no smoking and alcohol; appropriate nutrition; Exclusion criteria: history or illness in heart disease; lung disease; kidny disease; gastrointestinal; thyroid; parathyroid; pancreas; diabetes; lupus; hypertension; epilepsy; viral infection; toxoplasmosis; STD; polycytemia vera; history and acute disease of malignancy; hyperemesis; threatened abortion; bleeding in pregnancy.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neonates Anthropometric Indexes. Timepoint: Postpartum. Method of measurement: Medical Records. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactEsmat Jafarbegloo
Tarbiat Modarres University
Outcome results
None listed